Company Profiles

driven by the PitchBook Platform

Cambrooke Therapeutics

Cambrooke Therapeutics
2000 FOUNDED
M&A STATUS
71-80 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Provider of dietary food products intended to offer patient focused therapeutic nutrition. The company's dietary food products target dietary management needs of people with metabolic disorders and renal diseases, such as Phenylketonuria (PKU), a rare condition in which infants are unable to break down the amino acid phenylalanine, enabling patients to receive effective treatment while carrying on with their normal daily lives.

Formerly Known As
Cambrooke Foods
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-Backed
Primary Industry
Food Products
Other Industries
Other Healthcare
Parent Company
Primary Office
4 Copeland Drive
Ayer, MA 01432
United States

+1 (866) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cambrooke Therapeutics’s full profile, request a free trial.

Cambrooke Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 10-Nov-2017 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 11-Apr-2016 000.00 Completed Generating Revenue
2. Later Stage VC (Series A) 02-Mar-2011 $18M $18.3M 0000 Completed Generating Revenue
1. Later Stage VC 28-Jun-2010 $250K $250K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Cambrooke Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 000 000 00 000 00.00
To view this company’s complete Cap Table, request access »

Cambrooke Therapeutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Galen Partners PE/Buyout Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0

Cambrooke Therapeutics Executive Team (11)

Name Title Board
Seat
Contact
Info
Howard Lossing Chief Executive Officer
Ridge Cromwell Chief Financial Officer
Chuck Sizer Ph.D Chief Science Officer
Paula Richard Controller
Lynn Paolella Co-Founder

3 Former Executives

You’re viewing 5 of 11 executives. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com